Rick E Winningham's Net Worth
$69.4 Million
Estimate Recalculated Jul 12, 2024 05:17PM EST
Who is Rick E Winningham?
Rick E Winningham has an estimated net worth of $69.4 Million. This is based on reported shares across multiple companies, which include THERAVANCE INC, Theravance Biopharma, Inc., Jazz Pharmaceuticals plc, and OncoMed Pharmaceuticals Inc.
SEC CIK
Rick E Winningham's CIK is 0001302443
Past Insider Trading and Trends
2012 was Rick E Winningham's most active year for acquiring shares with 12 total transactions. Rick E Winningham's most active month to acquire stocks was the month of July. 2011 was Rick E Winningham's most active year for disposing of shares, totalling 19 transactions. Rick E Winningham's most active month to dispose stocks was the month of July. 2013 saw Rick E Winningham paying a total of $3,731,247.19 for 413,911 shares, this is the most they've acquired in one year. In 2013 Rick E Winningham cashed out on 704,909 shares for a total of $10,913,052.93, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
THERAVANCE INC (INVA) Snapshot price: $15.615
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.44% | -96.25K |
—
|
—
| 825.39K |
Aug 15
| |||
Form 4
| +7.26% | 62.4K |
—
|
—
| 921.64K |
Jun 16
| |||
Form 4
| +22.22% | 156.2K |
—
|
—
| 859.24K |
Jun 2
| |||
Form 4
| -6.67% | -50.23K |
$26.86 | -$1,349,043.50 | 703.04K |
May 9
| |||
Form 4
| +12.30% | 82.5K |
—
|
—
| 753.26K |
Apr 27
| |||
Form 4
| -1.37% | -9.30K |
$39.98 | -$371,694.06 | 670.76K |
Feb 20
| |||
Form 4
| -1.46% | -10.05K |
$36.40 | -$365,674.40 | 680.06K |
Nov 20
| |||
Form 4
| -3.14% | -22.35K |
$40.03 | -$894,790.59 | 690.11K |
Scheduled
|
Sep 12
| ||
Form 4
| -1.39% | -10.05K |
$35.89 | -$360,550.94 | 712.46K |
Aug 20
| |||
Form 4
| +1.55% | 11K |
—
|
—
| 722.5K |
Jul 24
| |||
Form 4
| -1.39% | -10.05K |
$37.01 | -$371,802.46 | 711.5K |
May 20
| |||
Form 4
| +21.90% | 129.63K |
$21.67 | -$4,865,921.65 | 721.55K |
Scheduled
|
Apr 30
| ||
Form 4
| -1.77% | -10.65K |
$22.10 | -$235,475.50 | 591.92K |
Feb 20
| |||
Form 4
| +1.86% | 11K |
—
|
—
| 602.58K |
Feb 7
| |||
Form 4
| +1.89% | 11K |
—
|
—
| 591.58K |
Oct 15
| |||
Form 4
| -1.81% | -10.68K |
$27.01 | -$288,493.81 | 580.58K |
Aug 20
| |||
Form 4
| +13.30% | 69.41K |
$15.53 | -$1,667,306.63 | 591.26K |
Scheduled
|
Aug 3
| ||
Form 4
| -2.01% | -10.68K |
$20.33 | -$217,144.73 | 521.85K |
May 20
| |||
Form 4
| +13.47% | 63.23K |
$6.33 | $400,070.03 | 532.53K |
May 4
| |||
Form 4
| -4.36% | -21.39K |
$18.54 | -$396,496.44 | 469.3K |
Feb 20
| |||
Form 4
| +2.29% | 11K |
—
|
—
| 490.69K |
Feb 15
| |||
Form 4
| -1.28% | -6.22K |
$22.34 | -$138,910.12 | 479.69K |
Nov 20
| |||
Form 4
| -20.82% | -127.75K |
$26.34 | -$3,364,268.86 | 485.91K |
Scheduled
|
May 10 - May 11
| ||
Form 4
| -9.43% | -63.87K |
$22.53 | -$1,439,058.69 | 613.65K |
Scheduled
|
Mar 1
| ||
Form 4
| +21.80% | 121.25K |
$15.38 | -$2,427,018.20 | 677.52K |
Scheduled
|
Feb 24 - Feb 28
| ||
Form 4
| +29.72% | 127.45K |
$14.95 | -$2,425,383.00 | 556.27K |
Scheduled
|
Feb 20 - Feb 23
| ||
Form 4
| +136.50% | 247.5K |
—
|
—
| 428.82K |
Feb 11
| |||
Form 4
| -2.97% | -5.55K |
$22.52 | -$125,098.60 | 181.32K |
Nov 20
| |||
Form 4
| +17.25% | 27.5K |
—
|
—
| 186.88K |
Oct 26
| |||
Form 4
| -2.22% | -3.62K |
$14.00 | -$50,736.00 | 159.38K |
Aug 20
| |||
Form 4
| -2.18% | -3.63K |
$13.02 | -$47,197.50 | 163K |
May 20
| |||
Form 4
| -1.43% | -2.41K |
$10.22 | -$24,660.86 | 166.63K |
Feb 20
| |||
Form 4
| +48.23% | 55K |
—
|
—
| 169.04K |
Feb 10
| |||
Form 4
| -2.03% | -2.36K |
$14.04 | -$33,190.56 | 114.04K |
Nov 20
| |||
Form 4
| -1.94% | -2.30K |
$15.65 | -$36,041.95 | 116.4K |
Aug 20
| |||
Form 4
| -1.90% | -2.30K |
$14.06 | -$32,380.18 | 118.71K |
May 20
| |||
Form 4
| +195.07% | 80K |
—
|
—
| 121.01K |
Mar 20
| |||
Form 4
| -4.89% | -2.11K |
$14.87 | -$31,345.96 | 41.01K |
Feb 20
| |||
Form 4
| +86.51% | 20K |
$10.47 | $209,420.98 | 43.12K |
Mar 11
| |||
Form 4
|
∞
| 23.12K |
—
|
—
| 23.12K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theravance Biopharma, Inc. (TBPH) Snapshot price: $8.5
CHIEF EXECUTIVE OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.86% | -16.00K |
$9.10 | -$145,572.70 | 1.84M |
May 20
| |||
Form 4
| +0.11% | 2.07K |
$9.85 | $20,369.80 | 1.85M |
May 15
| |||
Form 4
| +19.35% | 300K |
—
|
—
| 1.85M |
Apr 2
| |||
Form 4
| -0.28% | -4.30K |
$8.64 | $23,362.56 | 1.55M |
Mar 15
| |||
Form 4
| -2.33% | -37.20K |
$8.92 | -$331,788.32 | 1.56M |
Feb 20
| |||
Form 4
| -0.98% | -15.80K |
$10.37 | -$163,887.48 | 1.6M |
Nov 20
| |||
Form 4
| -0.97% | -15.80K |
$9.70 | -$153,298.80 | 1.61M |
Aug 20
| |||
Form 4
| -0.96% | -15.80K |
$11.21 | -$177,162.84 | 1.63M |
May 20
| |||
Form 4
| +25.13% | 330K |
—
|
—
| 1.64M |
Mar 1
| |||
Form 4
| -2.77% | -37.42K |
$10.44 | -$390,664.80 | 1.31M |
Feb 20
| |||
Form 4
| -4.18% | -59.00K |
$11.19 |
—
| 1.35M |
Dec 13 - Dec 14
| |||
Form 4
| -1.11% | -15.80K |
$10.85 | -$171,473.40 | 1.41M |
Nov 20
| |||
Form 4
| -1.10% | -15.80K |
$9.34 | -$147,609.36 | 1.42M |
Aug 19
| |||
Form 4
| -0.76% | -11.03K |
$8.74 | -$96,358.50 | 1.44M |
May 20
| |||
Form 4
| +13.29% | 170K |
—
|
—
| 1.45M |
Feb 25
| |||
Form 4
| -1.74% | -22.71K |
$9.61 | -$218,243.10 | 1.28M |
Feb 18
| |||
Form 4
| -0.87% | -11.40K |
$8.36 | -$95,337.44 | 1.3M |
Nov 19
| |||
Form 4
| -0.86% | -11.40K |
$14.05 | -$160,226.20 | 1.31M |
Aug 20
| |||
Form 4
| -0.85% | -11.40K |
$17.80 | -$202,991.20 | 1.32M |
May 20
| |||
Form 4
| -7.64% | -110.35K |
$18.79 | -$2,073,438.92 | 1.33M |
Feb 20
| |||
Form 4
| +13.33% | 170K |
—
|
—
| 1.45M |
Feb 8
| |||
Form 4
| -1.08% | -13.95K |
$17.21 | -$240,010.66 | 1.28M |
Nov 20
| |||
Form 4
| -1.07% | -13.95K |
$18.22 | -$254,096.12 | 1.29M |
Aug 20
| |||
Form 4
| -1.06% | -13.95K |
$26.67 | -$371,939.82 | 1.3M |
May 20
| |||
Form 4
| -6.86% | -96.85K |
$25.90 | -$2,508,415.00 | 1.32M |
Feb 20
| |||
Form 4
| +31.46% | 338K |
—
|
—
| 1.41M |
Feb 3
| |||
Form 4
| -0.80% | -8.68K |
$17.60 | -$152,732.80 | 1.07M |
Nov 20
| |||
Form 4
| -0.79% | -8.68K |
$21.51 | -$186,663.78 | 1.08M |
Aug 20
| |||
Form 4
| -0.79% | -8.68K |
$19.84 | -$172,171.52 | 1.09M |
May 20
| |||
Form 4
| -1.21% | -13.48K |
$27.00 | -$363,879.00 | 1.1M |
Feb 20
| |||
Form 4
| +39.83% | 317K |
—
|
—
| 1.11M |
Feb 5
| |||
Form 4
| -1.92% | -15.56K |
$24.79 | -$385,658.03 | 795.94K |
Nov 20
| |||
Form 4
| -1.69% | -15.56K |
$26.95 | -$419,261.15 | 904.06K |
Aug 20
| |||
Form 4
| -6.85% | -67.62K |
$24.31 | -$1,643,769.27 | 919.62K |
May 20
| |||
Form 4
| +11.90% | 105K |
—
|
—
| 987.24K |
May 14
| |||
Form 4
| -1.45% | -13.01K |
$29.09 | -$378,315.45 | 881.37K |
Feb 20
| |||
Form 4
| +3.23% | 28K |
—
|
—
| 894.38K |
Feb 12
| |||
Form 4
| +1.17% | 10K |
$24.50 | $245,000.00 | 866.38K |
Aug 11
| |||
Form 4
| -1.77% | -15.46K |
$36.83 | -$569,391.80 | 856.38K |
May 20
| |||
Form 4
| -3.68% | -33.26K |
$33.78 | -$1,123,657.92 | 870.13K |
Feb 20
| |||
Form 4
| +3.20% | 28K |
—
|
—
| 903.4K |
Feb 6
| |||
Form 4
| -0.95% | -8.36K |
$31.96 | -$267,185.60 | 875.4K |
Nov 20
| |||
Form 4
| +46.51% | 280K |
—
|
—
| 882.06K |
Mar 15
| |||
Form 4
| +7.24% | 80K |
$11.96 | $948,932.40 | 1.19M |
Aug 14 - Aug 17
| |||
Form 4
| -0.28% | -1.48K |
$19.52 | -$28,889.60 | 520.16K |
Feb 20
| |||
Form 4
| +92.07% | 250.06K |
—
|
—
| 521.64K |
Aug 20 - Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jazz Pharmaceuticals plc (JAZZ) Snapshot price: $123.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +21.30% | 1.83K |
$138.16 | -$171,454.57 | 10.44K |
Aug 11 - Aug 14
| |||
Form 4
| +20.62% | 1.47K |
$152.32 | -$165,879.31 | 8.61K |
Aug 5 - Aug 8
| |||
Form 4
| -15.47% | -1.31K |
$147.96 | -$193,235.76 | 7.14K |
Aug 6
| |||
Form 4
| +36.24% | 2.25K |
—
|
—
| 8.44K |
Jul 29
| |||
Form 4
| +40.10% | 1.77K |
$125.87 | -$117,184.88 | 6.2K |
Aug 6 - Aug 7
| |||
Form 4
| +36.97% | 1.19K |
$135.65 | -$98,482.19 | 4.42K |
Aug 8 - Aug 9
| |||
Form 4
| -55.38% | -6.14K |
$120.24 | -$2,352,745.75 | 4.95K |
Aug 9 - Aug 10
| |||
Form 4
| +6.77% | 703 |
$142.37 | -$94,247.89 | 11.09K |
Aug 10 - Aug 11
| |||
Form 4
| -32.49% | -5.00K |
$150.00 | -$750,000.00 | 10.39K |
Jun 1
| |||
Form 4
| -3.95% | -633.00 |
$136.45 | -$86,372.85 | 15.39K |
Aug 15
| |||
Form 4
| +9.31% | 1.36K |
—
|
—
| 16.02K |
Aug 11
| |||
Form 4
| +3.60% | 509 |
$180.00 | -$144,177.51 | 14.66K |
Aug 7 - Aug 10
| |||
Form 4
| -7.13% | -1.09K |
$133.15 | -$144,734.05 | 14.15K |
Aug 12
| |||
Form 4
| +12.14% | 1.65K |
—
|
—
| 15.24K |
Aug 7
| |||
Form 4
| -66.93% | -27.50K |
$140.00 | -$3,850,000.00 | 13.59K |
Scheduled
|
Apr 17
| ||
Form 4
| -2.54% | -1.07K |
$81.86 | -$87,590.20 | 41.09K |
Aug 13
| |||
Form 4
| +5.64% | 2.25K |
—
|
—
| 42.16K |
Aug 8
| |||
Form 4
| +5.97% | 2.25K |
—
|
—
| 39.91K |
Aug 9
| |||
Form 4
|
∞
| 37.66K |
—
|
—
| 37.66K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -100.00% | -37.66K |
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
∞
| 37.66K |
$31.97 | $80.20 | 37.66K |
Jan 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
OncoMed Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||